Merindol N, Riquet A, Szablewski V, Eliaou J-F, Puisieux A, Bonnefoy N
Université de Lyon and INSERM U1111, Lyon, France.
1] IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U896, Université Montpellier 1, Montpellier, France [2] Département de Biopathologie, Centre Hospitalier Régional Universitaire de Montpellier et Faculté de Médecine, Université Montpellier 1, Montpellier, France.
Blood Cancer J. 2014 Apr 25;4(4):e206. doi: 10.1038/bcj.2014.22.
Twist1 and Twist2 (Twist1-2) are two transcription factors, members of the basic helix-loop-helix family, that have been well established as master transcriptional regulators of embryogenesis and developmental programs of mesenchymal cell lineages. Their role in oncogenesis in epithelium-derived cancer and in epithelial-to-mesenchymal transition has also been thoroughly characterized. Recently, emerging evidence also suggests a key role for Twist1-2 in the function and development of hematopoietic cells, as well as in survival and development of numerous hematological malignancies. In this review, we summarize the latest data that depict the role of Twist1-2 in monocytes, T cells and B lymphocyte activation, and in associated hematological malignancies.
Twist1和Twist2(Twist1-2)是两种转录因子,属于碱性螺旋-环-螺旋家族成员,已被确认为胚胎发生和间充质细胞谱系发育程序的主要转录调节因子。它们在上皮源性癌症的肿瘤发生以及上皮-间质转化中的作用也已得到充分表征。最近,新出现的证据还表明Twist1-2在造血细胞的功能和发育以及众多血液系统恶性肿瘤的存活和发展中起关键作用。在本综述中,我们总结了描述Twist1-2在单核细胞、T细胞和B淋巴细胞活化以及相关血液系统恶性肿瘤中作用的最新数据。